Quantcast Pharmaceutical Industry News - Congoo
 
 
Log In
  COMPLETE INDUSTRY LIST >> PHARMACEUTICAL INDUSTRY    Get our Pharmaceutical Industry daily Briefing     
Accounting
Advertising industry
Aerospace & defense
Aerospace related
Agriculture
Airline industry
ASP
Automotive industry
Banking
Biological sciences
Biotech
Blogging
Book publishing
Broadcasting industry
Business related
Cable industry
Cancer
Charities
Chemicals industry
Clothing industry
Commodities
Communications equipment
Computer games
Computer security
Construction
Corporate finance
Corporate governance
Crime & Punishment
CRM
Database industry
Derivatives
Developer
Digital television
E-commerce
Economics
Emerging markets
Energy
Engineering Industry
Engineering General
Enterprise computing
Entrepreneur
Environment
Equity markets
European business
Fed watch
Finance news
Firearms industry
Food industry
Forex markets
Fund management
Genetics
GMO
Graphics industry
Handhelds
Healthcare
Hospitality industry
Human resources
Human rights
Human sciences
Imaging equipment
Insurance industry
Internet consultancies
Internet Europe
Internet news
IP and patents
IPO
Java
Job markets
Journalism
Knowledge management
Law
Law related
Leisure goods
Linux
Logistics
Macintosh
Management
Marketing
Media
Medical
Mergers & acquisitions
Metals industry
Mining and metals
Mobile industry
Mortgage industry
Movie business
Music business
Mutual funds
Nanotechnology
Newspaper publishing
Oil & gas
Online banking
Online broker
Online content
Online information
Online legal issues
Online marketing
Online portals
Open source
Outsourcing
Packaging & paper
Packaging related
Paper
PC industry
PC software
Personal data privacy
Personal finance
Personal technology
Pharmaceutical Industry
Physical Sciences
Plastics industry
Police
Public health
Real Estate industry
Religion
Retail investor
Retail sector
RFID
Robotics
RSS
Science
Securities industry
Semiconductor industry
Shipping industry
Silicon Valley
Small business
Software downloads
Space science
Steelmaking
Stock Exchanges
Stockwatch
Tech stocks
Technology
Technology news
Telecom industry
Textiles
Textiles related
Tobacco industry
Trade
Transportation industry
Transportation related
Travel industry
UK law
US education
US immigration
US politics
US security
US social policy
Utilities News
Venture Capital
Web developer
Web services
Webmaster tips
Website owner
Windows OS
Wireless sector
XML & metadata
 
 



CannaPharmaRx Teams Up With The Catalyst Agency to Build and Introduce CMR, a Longitudinal   - 4 Hours ago
CARNEYS POINT, NJ --(Marketwired - January 29, 2015) - CannaPharmaRx, Inc. (OTCQB: GDHC) , the New Jersey-based pharmaceutical company, is launching its proprietary Cannabinoid Medicines Registry (SM)
  
    



3 Steady Eddie Europe Stocks   - 4 Hours ago
Type Ticker, Company or Fund Name You have been redirected here from Hemscott.com as we are merging our websites to provide you with a one-stop shop for all your investment research needs. Get Started:
  
    




UPDATE - SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action   - 4 Hours ago
NEW YORK, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf
all 1 news articles >>
  
    



Aquinox Pharmaceuticals to Present at Upcoming Investor Conferences   - 4 Hours ago
VANCOUVER, British Columbia, Jan. 29, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics
  
    



UMD Start-up SD Nanosciences' Customized Soap Bubbles Set to Transform Drug and   - 4 Hours ago
University of Maryland researchers are covering soap bubbles with biomaterials that act as a disguise, tricking the body's cells into mistaking the capsule for a bacterium, a cancer cell or almost any
  
    



Merck KGaA abandons Symphogen's cancer drug ahead of Phase III   - 4 Hours ago
Merck KGaA, in the process of paring down its pipeline, is walking away from a $625 million deal with Symphogen and handing back the company's lead asset, a targeted cancer treatment in mid-stage trials.
  
    


Ernst & Young - The right transaction Sponsored
No matter what the size of your company, where it is located or the business you are in, transactions can help your company grow, prosper or reinvent itself. The Ernst and Young Transaction professionals can play a critical role at every step of the deal lifecycle.  Learn More



Biogen Idec quietly carves out a leading role in developing gene therapy for hemophilia   - 4 Hours ago
Biogen Idec has taken its next big step toward building its own gene therapy program for hemophilia A and B. The Big Biotech and its newly named in-house expert Olivier Danos have executed a research
  
    



Trans-Pacific trade talks on biologics not even close to agreement: USTR   - 4 Hours ago
SINGAPORE--Don't look for any Trans-Pacific Trade Partnership agreement on patent lengths for biologics this year. That was the message delivered at a congressional hearing on Tuesday. Though U.S. Trade
  
    



Celgene posts double-digit rise in Q4 sales, profit, boosted by Revlimid   - 4 Hours ago
Celgene's fourth-quarter revenue jumped 19 percent year-over-year to $2.1 billion, meeting analyst estimates, buoyed by the performance of Revlimid, whose sales lifted 16 percent to $1.3 billion. Net
  
    


Reach your target audience with AdBlade! Sponsored
- Brand your product
- Create awareness in your product
- Drive traffic

And do it all on a CPC basis of as little as 50 cents.  Try AdBlade and begin reaching your targ.  Learn More



Jazz Pharmaceuticals: Upside Opportunities   - 4 Hours ago
Summary Strong financial performance during the 2014 with 34% revenue growth and 57% EBITDA margin. Market leadership and absence of competition in markets of particular drugs treating cataplexy, EDS
  
    



Actinium to Participate in the Canaccord Genuity Rare Disease and Biopharma One-on-One   - 4 Hours ago
Comments January 28, 2015 - NEW YORK, NY NEW YORK, NY--(Marketwired - January 28, 2015) - Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing
  
    



AstraZeneca announces four collaborations to use CRISPR technology for genome editing   - 4 Hours ago
AstraZeneca today announced four research collaborations aimed at harnessing the power of CRISPR, a pioneering genome-editing technique, across its entire discovery platform in the company’s key therapeutic
  
    


Your sponsored post can go right here! Sponsored

Congoo’s B2B information portal now receives over 1 million visits per month.  Congoo provides a highly influential audience comprehensive news and information within their industry.  Reach a coveted audience of senior executives, affluent males and opinion leaders. Get the Media Kit




Abbott Laboratories (ABT) Q4 2014 Results - Earnings Call Webcast   - 4 Hours ago
The following audio is from a conference call that will begin on January 29, 2015 at 09:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion. Source:
  
    



Ranbaxy loses US generic exclusivity over $6 bn Nexium [DNA : Daily News & Analysis   - 4 Hours ago
Mumbai: Drugmaker Ranbaxy on Tuesday said that the US Food and Drug Administration (FDA) has determined that the Indian drug manufacturer has forfeited its 180-day exclusivity to sell generic version
all 1 news articles >>
  
    



Epizyme Appoints Robert A. Copeland, Ph.D., as President of Research   - 4 Hours ago
Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced that Robert A. Copeland,
  
    



Abbott Laboratories Profit Grows 54%   - 4 Hours ago
Abbott has been realigning its business in a series of deals. Last year Abbott reached an agreement to shed a portion of its generics pharmaceuticals business to Mylan Inc., a transaction that punctuated
  
    



Ex-FDA chief says J&J knew drug linked to male breast growth.   - 4 Hours ago
(Bloomberg) -- Johnson & Johnson, which paid more than $2 billion to resolve a criminal probe over its antipsychotic drug Risperdal, knew as early as 2001 that the medication caused boys to grow breasts,
  
    



Roche Forecasts Higher Earnings After 2014 EPS Misses Estimates   - 1/28/2015
(Bloomberg) -- Roche Holding AG, the world’s biggest seller of cancer drugs, forecast that revenue and profit will increase in 2015 after last year’s earnings missed analysts’ estimates. Sales will
  
    



Diagnostics, Tamiflu help Roche full-year sales beat poll   - 1/28/2015
ZURICH Jan 28 (Reuters) - Swiss drugmaker Roche expects sales and profits to grow at a similar pace to last year, after a strong performance by its diagnostics unit and flu drug Tamiflu helped full-year
  
    



Advanced Gender Selection Program Announced at LIV Fertility...   - 1/28/2015
The LIV Fertility Center in Mexico introduces an exceedingly innovative and affordable gender selection program, adding to its all-embracing fertility services. With its leading IVF and donor programs,
all 2 news articles >>
  
    



Rally in Drug-Store Chain’s Stock Makes Ruan a New Billionaire   - 1/28/2015
(Bloomberg) -- Ruan Hongxian became a billionaire with a rally in the shares of Yunnan Hongxiang Yixintang Pharmaceutical Co., China’s third-largest publicly traded operator of drug stores. Ruan, 50,
  
    



Cancer patients look to India for lifesaving drugs   - 1/28/2015
Leukemia patient Lu Yong borrowed the idea from the Oscar-winning film Dallas Buyers Club and smuggled unapproved, Indian-made drugs for himself and 1,000 others to get medicines at an affordable price.
all 2 news articles >>
  
    



U.S. multinationals hit hard by strong dollar, to bleed further into 2015   - 1/28/2015
© REUTERS/Siphiwe Sibeko American dollar notes are displayed in this photo illustration in Johannesburg August 13, 2014. A slew of U.S. multinational companies, from DuPont (DD.N) to
all 8 news articles >>
  
    



Still looking to buy, Pfizer revenue, profit hit by currency-exchange rates [The   - 1/28/2015
Jan. 28--Drugmaker Pfizer Inc. might grow, break up, or some combination of both. Chief executive officer Ian Read said Tuesday that Pfizer will keep looking for companies to buy and is taking the next
  
    



Roche FY14 Profit Declines, Lifts Dividend; Sees Growth In FY15 - Quick Facts   - 1/28/2015
Swiss drugmaker Roche Holding AG (RHHBY.PK) reported Wednesday that its fiscal 2014 net income, on IFRS basis, declined 16 percent to 9.54 billion Swiss francs from last year's 11.37 billion francs.
  
    
*Votes may take up to 30 minutes to influence article rank order
Featured Members
Shannon Peryea Shannon Peryea
Vice President, Executive Recruiting
Pharma Industry
Nancy Deeg Nancy Deeg
CEO
Pharma Industry
John Griffith John Griffith
Pharma Industry
Melissa Lowenstein Melissa Lowenstein
Pharma Industry

  Add your Profile
  View more profiles

   




 
 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2015 Congoo.com. All Rights Reserved.